StonvexLoading…
StonvexStonvexStonvexCore line items from FRME's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $248.57M | $924.79M | $687.35M | $452.25M |
Operating Income | $27.09M | $259.11M | $193.62M | $128.34M |
Net Income | $28.16M | $226.00M | $168.94M | $112.17M |
EPS (Diluted) | $0.45 | $3.88 | $2.90 | $1.92 |
Total Assets | $21.07B | $19.03B | $18.81B | $18.59B |
Total Liabilities | $18.40B | $16.56B | $16.40B | $16.24B |
Cash & Equivalents | $98.08M | $84.16M | $88.08M | $81.57M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 62.51M | 56.95M | 57.19M | 57.27M |